S-100β protein - Serum levels in children with brain neoplasms and its potential as a tumor marker

Journal of Neuro-Oncology

Volumn 67, Issue 3, 2004, Pages 345-349

  Rajendra, Anil ^a   Spinella, Philip C ^a   Drott, Henry R ^a   Dominguez, Troy E ^a   Sutton, Leslie ^a   Helfaer, Mark ^a  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

Astrocytomas; Blood brain barrier; Brain neoplasms; Children; S 100 protein; Serum

Indexed keywords

CORTICOSTEROID; PROTEIN S100B; TUMOR MARKER; NERVE GROWTH FACTOR; PROTEIN S 100; S 100 CALCIUM BINDING PROTEIN BETA SUBUNIT; S-100 CALCIUM-BINDING PROTEIN BETA SUBUNIT;

ADOLESCENT; ARTICLE; ASTROCYTOMA; BLOOD LEVEL; BRAIN TUMOR; CHILD; CHILDHOOD CANCER; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; HUMAN; PROSPECTIVE STUDY; TEACHING HOSPITAL; TUMOR BIOPSY; TUMOR CLASSIFICATION; URBAN AREA; BLOOD; CASE CONTROL STUDY; COMPARATIVE STUDY; INFANT; PATHOLOGY; PRESCHOOL CHILD;

ADOLESCENT; ASTROCYTOMA; BRAIN NEOPLASMS; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; HUMANS; INFANT; NERVE GROWTH FACTORS; PROSPECTIVE STUDIES; S100 PROTEINS; TUMOR MARKERS, BIOLOGICAL;

EID: 2942744548     PISSN: 0167594X     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:NEON.0000024216.15923.77     Document Type: Article

References (24)

1. Ghanem G, Loir B, Morandini R, Sales F, Lienard D, Eggermont A, Lejeune F: On the release and half-life of S-100β protein in the peripheral blood of melanoma patients. Int J Cancer 94: 586-590, 2001
2. Zeizmann CW, Fritz G, Schafer BW: S-100 proteins: structure, functions, and pathology. Front Biosci. 7: 1356-1368, 2002
3. Gazzolo D, Bruschettini M, Lituania M, Serra G, Bonacci W, Michetti F: Increased urinary S-100β protein as an early indicator of intraventricular hemorrhage in preterm infants: correlation with the grade of hemorrhage. Clin Chem 47: 1836-1838, 2001
4. Donato R: S-100: a multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional roles. Int J Biochem Cell Biol 33: 637-668, 2001
5. Kaskel P, Berking C, Sander S, Volkenandt M, Peter RU, Krahn G: S-100 protein in peripheral blood: a marker for melanoma metastases. J Am Acad Dermatol 41: 962-969, 1999
6. Henze G, Dummer R, Joller-Jemelka HI, Boni R, Burg G: Serum S100 - A marker for disease monitoring in metastatic melanoma. Dermatology 194: 208-212, 1997
7. Spinella PC, Dominguez TD, Drott HR, Huh J, McCormick L, Rajendra A, Argon J, McIntosh T, Helfaer M: S-100β protein - Serum levels in healthy children and its association with outcome in pediatric traumatic brain injury. Crit Care Med 31: 939-945, 2003
8. Rothoerl RD, Woertgen C, Holzschuh M, Metz C, Brawanski A: S-100 serum levels after minor and major head injury. J Trauma 45: 765-767, 1998
9. Raabe A, Grolms C, Sorge O, Zimmerman M, Seifert V: Serum S-100β protein in severe head injury. Neurosurgery 45: 477-483, 1999
10. Woertgen C, Rothoerl RD, Holzschuh M, Metz C, Brawanski A: Comparison of selial S-100 and NSE serum measurements after severe head injury. Acta Neurochir 139: 1161-1165, 1997
11. Missler U, Wiesmann M, Friedrich C, Kaps M: S-100 protein and neuron-specific enolase concentrations in blood as indicators of infarction volume and prognosis in acute ischemic stroke. Stroke 28: 1956-1960, 1997
12. Lindberg L, Olsson A-K, Anderson K, Jogi P: Serum S-100 protein levels after pediatric cardiac operations: a possible new marker for postperfusion cerebral injury. J Thorac Cardiovasc Surg 116: 281-285, 1998
13. Rosen H, Rosengren L, Herlitz J, Blomstrand C: Increased serum levels of the S-100 protein are associated with hypoxic brain damage after cardiac arrest. Stroke 29: 473-477, 1998
14. Bottiger BW, Mobes S, Glatzer R, Bauer H, Gries A, Bartsch P, Motsch J, Martin E: Astroglial protein S-100 is an early and sensitive marker of hypoxic brain damage and outcome after cardiac arrest in humans. Circulation 103: 2694-2698, 2001
15. Missler U, Wandinger KP, Wiesmann M, Kaps M, Wessel K: Acute exacerbation of multiple sclerosis increases plasma levels of S-100 protein. Acta Neurol Scand 96: 142-144, 1997
16. Bartosik-Psujck H, Stelmasiak Z: Biochemical markers of damage of the central nervous system in multiple sclerosis. Ann Univ Mariae Curie Sklodowska 56: 389-392, 2001
17. Infante JR, Torres-Avisbal M, Martinez A, Vallejo JA, Aguilera C, Contreras P, Benitez A, Latre JM: Evaluation of tumor marker S-100 in cerebrospinal fluid from subjects with nonischemic brain pathologies. Tumour Biol 21: 38-45, 2000
18. de Vries J, Thijssem WAMH, Snels SEA, Menovsky T, Peer NGM, Lamers KJB: Intraoperative. values of S-100 protein, myelin basic protein, lactate, and albumin in the CSF and serum of neurosurgical patients. J Neurol Neurosurg Psychiatry 71: 671-674, 2001
19. Kapural M, Krizanac-Bengez Lj, Barnett G, Perl J, Masaryk T, Apollo D, Rasmussen P, Mayberg MR, Janigro D: Serum S-100β as a possible. marker of blood-brain barrier disruption. Brain Res 940: 102-104, 2002
20. Rowland LP, ed. Merritt's Neurology. Lippincott Williams & Wilkins, Philadelphia, PA, 2000, p 302
21. Petty MA, Lo EH: Junctional complexes of the. blood-brain barrier: permeability changes in neuroinflammation. Prog Neurobiol 68: 311-323, 2002
22. Perry VH, Anthony DC, Bolton SJ, Brown HC: The blood-brain barrier and the inflammatory response. Mol Med Today 3: 335-341, 1997
23. Gardenfors A, Nilsson F, Skagerberg G, Ungerstedt U, Nordstrom CH: Cerebral physiological and biochermcal changes during vasogenic brain oedema induced by intrathecal injection of bacterial lipopolysaccharides in piglets. Acta Neurochir 144: 601-608; discussion 608-609, 2002
24. Reiber H: Dynamics of brain-deprived proteins in cerebrospinal fluid. Clin Chim Acta 310: 173-186, 2001